Intra-Cellular Therapies Inc.'s ticker is and the CUSIP is 46116X010.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $6,509,000 | +22.8% | 299,942 | 0.0% | 0.56% | +16.2% |
| Q2 2018 | $5,300,000 | -16.1% | 299,942 | 0.0% | 0.48% | -19.5% |
| Q1 2018 | $6,314,000 | +53.0% | 299,942 | +5.3% | 0.60% | +49.8% |
| Q4 2017 | $4,126,000 | -8.2% | 284,942 | 0.0% | 0.40% | -6.3% |
| Q3 2017 | $4,496,000 | +27.0% | 284,942 | 0.0% | 0.43% | +19.3% |
| Q2 2017 | $3,539,000 | -23.6% | 284,942 | 0.0% | 0.36% | -21.0% |
| Q1 2017 | $4,630,000 | +7.7% | 284,942 | 0.0% | 0.45% | +4.1% |
| Q4 2016 | $4,300,000 | +22.7% | 284,942 | +23.9% | 0.44% | +21.5% |
| Q3 2016 | $3,504,000 | -54.3% | 229,942 | +16.5% | 0.36% | -55.2% |
| Q2 2016 | $7,665,000 | +39.6% | 197,442 | 0.0% | 0.80% | +40.9% |
| Q1 2016 | $5,489,000 | -44.1% | 197,442 | +8.2% | 0.57% | -37.1% |
| Q4 2015 | $9,814,000 | -0.0% | 182,442 | -25.6% | 0.90% | +1.8% |
| Q3 2015 | $9,815,000 | +15.9% | 245,142 | -7.5% | 0.88% | +27.2% |
| Q2 2015 | $8,471,000 | +33.8% | 265,142 | 0.0% | 0.70% | +33.6% |
| Q1 2015 | $6,332,000 | +35.3% | 265,142 | 0.0% | 0.52% | +39.3% |
| Q4 2014 | $4,680,000 | +28.7% | 265,142 | 0.0% | 0.37% | +29.0% |
| Q3 2014 | $3,635,000 | +7.8% | 265,142 | +32.6% | 0.29% | +5.8% |
| Q2 2014 | $3,372,000 | -7.3% | 200,000 | 0.0% | 0.27% | -9.9% |
| Q1 2014 | $3,636,000 | – | 200,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|